NCT00913705View on ClinicalTrials.gov

Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

624

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2009

Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG

Neoadjuvant chemotherapy (taxol and carboplatin)

Taxol: 200mg/m2 infusion over 3 hours; Carboplatin: AUC= 6 at the end of the Taxol infusion. Administration of 3 cycles at 21-day intervals. Prior to surgery.

DRUG

Adjuvant chemotherapy (taxol and carboplatin)

Taxol: 200mg/m2 infusion over 3 hours; Carboplatin: AUC= 6 at the end of the Taxol infusion. Administration of 3 cycles at 21 days interval. Post-surgery

PROCEDURE

Surgery

Surgery

All Listed Sponsors
lead

Spanish Lung Cancer Group

OTHER

NCT00913705 - Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer | Biotech Hunter | Biotech Hunter